Brief: Alk-Abello FDA Approves Odactra For Treatment Of House Dust Mite Allergy In Young Children
27/02/2025 20:52
Feb 27 (Reuters) - ALK-Abello A/S ALKb.CO: REG-FDA APPROVES ODACTRA® FOR THE TREATMENT OF HOUSE DUST MITE ALLERGY IN YOUNG CHILDREN ALK-ABELLO A/S: APPROVAL IS NOT EXPECTED TO AFFECT ALK'S FINANCIAL OUTLOOK FOR 2025. Source text: ID:nGNE1SrKQx Further company coverage: [ALKb.CO] ((Reuters.Briefs@thomsonreuters.com;))